Literature DB >> 14680699

Allelic exchange in Francisella tularensis using PCR products.

Crystal M Lauriano1, Jeffrey R Barker, Francis E Nano, Bernard P Arulanandam, Karl E Klose.   

Abstract

We describe here a technique for allelic exchange in Francisella tularensis subsp. novicida utilizing polymerase chain reaction (PCR) products. Linear PCR fragments containing gene deletions with an erythromycin resistance cassette insertion were transformed into F. tularensis. The subsequent ErmR progeny were found to have undergone allelic exchange at the correct location in the genome; the minimum flanking homology necessary was 500 bp. This technique was used to create mglA, iglC, bla, and tul4 mutants in F. tularensis subsp. novicida strains. The mglA and iglC mutants were defective for intramacrophage growth, and the tul4 mutant lacked detectable Tul4 by Western immunoblot, as expected. Interestingly, the bla mutant maintained resistance to ampicillin, indicating the presence of multiple ampicillin resistance genes in F. tularensis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680699     DOI: 10.1016/S0378-1097(03)00820-6

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  50 in total

1.  Identification of Francisella tularensis genes affected by iron limitation.

Authors:  Kaiping Deng; Robert J Blick; Wei Liu; Eric J Hansen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Utilization of an unstable plasmid and the I-SceI endonuclease to generate routine markerless deletion mutants in Francisella tularensis.

Authors:  Joseph Horzempa; Robert M Q Shanks; Matthew J Brown; Brian C Russo; Dawn M O'Dee; Gerard J Nau
Journal:  J Microbiol Methods       Date:  2009-10-29       Impact factor: 2.363

3.  A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate.

Authors:  Larry A Gallagher; Elizabeth Ramage; Michael A Jacobs; Rajinder Kaul; Mitchell Brittnacher; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

4.  Construction and characterization of a highly efficient Francisella shuttle plasmid.

Authors:  Tamara M Maier; Andrea Havig; Monika Casey; Francis E Nano; Dara W Frank; Thomas C Zahrt
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

5.  Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.

Authors:  Jieh-Juen Yu; Tatareddy Goluguri; M Neal Guentzel; James P Chambers; Ashlesh K Murthy; Karl E Klose; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

6.  Characterization of fig operon mutants of Francisella novicida U112.

Authors:  Katalin Kiss; Wei Liu; Jason F Huntley; Michael V Norgard; Eric J Hansen
Journal:  FEMS Microbiol Lett       Date:  2008-06-18       Impact factor: 2.742

7.  The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression.

Authors:  Audrey Chong; Tara D Wehrly; Vinod Nair; Elizabeth R Fischer; Jeffrey R Barker; Karl E Klose; Jean Celli
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

8.  The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence.

Authors:  Jeffrey R Barker; Audrey Chong; Tara D Wehrly; Jieh-Juen Yu; Stephen A Rodriguez; Jirong Liu; Jean Celli; Bernard P Arulanandam; Karl E Klose
Journal:  Mol Microbiol       Date:  2009-12       Impact factor: 3.501

9.  Identification of differentially regulated francisella tularensis genes by use of a newly developed Tn5-based transposon delivery system.

Authors:  Blake W Buchan; Molly K McLendon; Bradley D Jones
Journal:  Appl Environ Microbiol       Date:  2008-03-14       Impact factor: 4.792

Review 10.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.